| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | IPILL, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | IPILL, INC. |
1st Quarter (Jan 1 - Mar 31) Registration |
— | — | |
| 2026 | ADIAL PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$10,000 | — | |
| 2026 | BULLBAG CORPORATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | CLEARMIND MEDICINE, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$10,000 | — | |
| 2026 | BREAKING BARRIERS TO SUBSTANCE USE RECOVERY |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$10,000 | — | |
| 2026 | ELSE NUTRITION GH LTD. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$10,000 | — | |
| 2026 | THE RECOVERY PLATFORM |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | RECCE PHARMACEUTICALS LTD |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | — | |
| 2026 | NEXALIN TECHNOLOGY INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| NEXALIN TECHNOLOGY INC. | 12 | $260,000 |
| RECCE PHARMACEUTICALS LTD | 11 | $200,000 |
| THE RECOVERY PLATFORM | 10 | $30,000 |
| BREAKING BARRIERS TO SUBSTANCE USE RECOVERY | 8 | $100,000 |
| ELSE NUTRITION GH LTD. | 8 | $70,000 |
| SCORPIUS BIOMANUFACTURING, INC. | 8 | $30,000 |
| ADIAL PHARMACEUTICALS, INC. | 7 | $60,000 |
| CLEARMIND MEDICINE, INC | 5 | $40,000 |
| BULLBAG CORPORATION | 5 | $20,000 |
| IPILL, INC. | 2 | — |
| Name | Disclosed Prior Position |
|---|---|
| RYAN KANE |